Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 24-hour postpartum magnesium sulfate for postpartum pre-eclampsia
RBR-83fs5drPhase 4Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Universidade Estadual de Campinas. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on RBR-83fs5dr.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-83fs5dr.